In summary, by examining gene expression patterns, we have developed a novel test that can predict SCC tumors with a high risk of metastasis and recurrence more accurately than any previous method. This test has the potential to usher in a new era of precision medicine for squamous cell skin cancer, allowing us to identify and treat the most dangerous tumors early. We are excited to further validate and refine this promising new diagnostic tool.